Cargando…
Preparation, Optimization and Characterization of Chitosan-coated Liposomes for Solubility Enhancement of Furosemide: A Model BCS IV Drug
Autores principales: | Moslehi, Mohammad, Mortazavi, S. Ali Reza, Azadi, Amir, Fateh, Samaneh, Hamidi, Mehrdad, Foroutan, S. Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462505/ https://www.ncbi.nlm.nih.gov/pubmed/32922494 http://dx.doi.org/10.22037/ijpr.2019.111834.13384 |
Ejemplares similares
-
BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide
por: Markovic, Milica, et al.
Publicado: (2020) -
Solubility, Permeability, and Dissolution Rate of Naftidrofuryl Oxalate Based on BCS Criteria
por: Kus-Slowinska, Marta, et al.
Publicado: (2020) -
Soluplus(®) polymeric nanomicelles improve solubility of BCS-class II drugs
por: Pignatello, Rosario, et al.
Publicado: (2022) -
Film-Forming Spray of Water-Soluble Chitosan Containing Liposome-Coated Human Epidermal Growth Factor for Wound Healing
por: Umar, Abd. Kakhar, et al.
Publicado: (2021) -
Nano-hydroxyapatite improves intestinal absorption of acetazolamide (BCS Class IV drug)–but how?
por: Kaneko, Kenichi, et al.
Publicado: (2022)